Kumar Raju Suresh, Almansour Abdulrahman I, Arumugam Natarajan, Kotresha D, Manohar Thota Sai, Venketesh S
Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia.
Department of Studies in Botany, Davangere University, Shivagangothri, Davangere 577007, Karnataka, India.
Saudi J Biol Sci. 2021 Jan;28(1):754-761. doi: 10.1016/j.sjbs.2020.11.005. Epub 2020 Nov 11.
Two series of dimethoxyindanone imbedded novel fluorinated spiropyrrolidine heterocyclic hybrids were synthesized employing two different less explored azomethine ylides and were measured for their efficiency as inhibitors for Alzheimer's disease. Among the spiropyrrolidine heterocyclic hybrids, the indole based fluorinated compound with a methoxy substituent at the position of the aryl ring exhibited the utmost potent AChE and BChE inhibitory activities with an IC of 1.97 ± 0.19 µM and 7.08 ± 0.20 µM respectively. The plausible mechanism of inhibition on ChE receptors was unveiled via molecular docking studies.
使用两种不同的较少被研究的甲亚胺叶立德合成了两个系列的嵌入二甲基茚满酮的新型氟化螺吡咯烷杂环化合物,并对其作为阿尔茨海默病抑制剂的效率进行了测定。在螺吡咯烷杂环化合物中,芳环α位带有甲氧基取代基的吲哚基氟化化合物表现出最强的乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BChE)抑制活性,其IC₅₀分别为1.97±0.19 μM和7.08±0.20 μM。通过分子对接研究揭示了对胆碱酯酶受体的可能抑制机制。